Literature DB >> 33850327

Is IL-6 a key cytokine target for therapy in COVID-19?

Simon A Jones1,2, Christopher A Hunter3.   

Abstract

Entities:  

Year:  2021        PMID： 33850327     DOI： 10.1038/s41577-021-00553-8

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  François-Xavier Lescure; Hitoshi Honda; Robert A Fowler; Jennifer Sloane Lazar; Genming Shi; Peter Wung; Naimish Patel; Owen Hagino
Journal:  Lancet Respir Med       Date:  2021-03-04       Impact factor: 30.700

2.  Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.

Authors:  Arvinder S Soin; Kuldeep Kumar; Narendra S Choudhary; Pooja Sharma; Yatin Mehta; Sushila Kataria; Deepak Govil; Vikas Deswal; Dhruva Chaudhry; Pawan Kumar Singh; Ashish Gupta; Vikas Agarwal; Suresh Kumar; Shashikala A Sangle; Rajesh Chawla; Suneetha Narreddy; Rahul Pandit; Vipul Mishra; Manoj Goel; Athimalaipet V Ramanan
Journal:  Lancet Respir Med       Date:  2021-03-04       Impact factor: 30.700
  2 in total
  39 in total

Review 1.  The intersection of COVID-19 and autoimmunity.

Authors:  Jason S Knight; Roberto Caricchio; Jean-Laurent Casanova; Alexis J Combes; Betty Diamond; Sharon E Fox; David A Hanauer; Judith A James; Yogendra Kanthi; Virginia Ladd; Puja Mehta; Aaron M Ring; Ignacio Sanz; Carlo Selmi; Russell P Tracy; Paul J Utz; Catriona A Wagner; Julia Y Wang; William J McCune
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

2.  The Role of Acupuncture for Long COVID: Mechanisms and Models.

Authors:  James E Williams; Jacques Moramarco
Journal:  Med Acupunct       Date:  2022-06-16

3.  Experimental Model of Pulmonary Inflammation Induced by SARS-CoV-2 Spike Protein and Endotoxin.

Authors:  Manoj Puthia; Lloyd Tanner; Ganna Petruk; Artur Schmidtchen
Journal:  ACS Pharmacol Transl Sci       Date:  2022-01-25

4.  Encephalitis with status epilepticus and stroke as complications of non-severe COVID-19 in a young female patient: a case report.

Authors:  Seungyon Koh; Yoon Seob Kim; Min Hye Kim; Young Hwa Choi; Jun Young Choi; Tae-Joon Kim
Journal:  BMC Neurol       Date:  2022-07-11       Impact factor: 2.903

5.  Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.

Authors:  Domenico Lo Tartaro; Anita Neroni; Annamaria Paolini; Rebecca Borella; Marco Mattioli; Lucia Fidanza; Andrew Quong; Carlene Petes; Geneve Awong; Samuel Douglas; Dongxia Lin; Jordan Nieto; Licia Gozzi; Erica Franceschini; Stefano Busani; Milena Nasi; Anna Vittoria Mattioli; Tommaso Trenti; Marianna Meschiari; Giovanni Guaraldi; Massimo Girardis; Cristina Mussini; Lara Gibellini; Andrea Cossarizza; Sara De Biasi
Journal:  Commun Biol       Date:  2022-06-16

6.  Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients.

Authors:  Wangyang Li; Georgios D Kitsios; William Bain; Chenxiao Wang; Tiao Li; Kristen V Fanning; Rushikesh Deshpande; Xuebin Qin; Alison Morris; Janet S Lee; Chunbin Zou
Journal:  mSystems       Date:  2022-05-18       Impact factor: 7.324

Review 7.  The human genetic epidemiology of COVID-19.

Authors:  Mari E K Niemi; Mark J Daly; Andrea Ganna
Journal:  Nat Rev Genet       Date:  2022-05-02       Impact factor: 59.581

Review 8.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

Review 9.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

Review 10.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.